<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Articles SYSTEM "HBI_DTD">
<Articles><Article><Journal><PublisherName></PublisherName><JournalTitle>International Journal of Preventive Medicine (Int J Prev Med)</JournalTitle><Issn>2008-7802</Issn><Volume>10</Volume><Issue>1</Issue><PubDate PubStatus="epublish"><Year>2019</Year><Month>01</Month><Day>23</Day></PubDate></Journal><title locale="en_US">Effect of Vitamin D on Non-Alcoholic Fatty Liver Disease: A Systematic Review of Randomized Controlled Clinical Trials</title><FirstPage>2008</FirstPage><LastPage>7802</LastPage><Language>EN</Language><AuthorList><Author><affiliation locale="en_US">Department of Basic Medical Sciences, Neyshabur University of Medical Sciences, Neyshabur</affiliation></Author><Author><affiliation locale="en_US">Student Research Committee, Neyshabur&#13;
University of Medical Sciences, Neyshabur,</affiliation></Author></AuthorList><History><PubDate PubStatus="received"><Year>2019</Year><Month>01</Month><Day>23</Day></PubDate></History><abstract locale="en_US">&lt;p&gt;&lt;span class="fontstyle0"&gt;New evidence suggests that low serum Vitamin D may cause nonalcoholic fatty liver disease (NAFLD). Hypovitaminosis D is associated with the severity and incidence of NAFLD. The objective of this study was to conduct a systematic review on randomized controlled trials (RCTs) assessing the effect of Vitamin D on serum metabolic profle among NAFLD patients. Databases including PubMed, Institute for Scientifc Information Web of Science, Scopus, and Google Scholar were searched up to November 2016. RCTs which studied Vitamin D effect on metabolic profles and liver function, and conducted among adults were included. Six articles were eligible&lt;br /&gt;to be considered in this systematic review. According to the result, Vitamin D supplementation might improve lipid profle and inﬂammatory mediators when compared with placebo. No article indicated signifcant effect of Vitamin D on liver enzymes except one article which revealed that&lt;br /&gt;Vitamin D together with calcium carbonate can reduce liver enzymes. Vitamin D supplementation may not improve anthropometric measures and glycemic index variables among patients with NAFLD. Vitamin D supplement might improve NAFLD symptoms, especially inﬂammatory&lt;br /&gt;mediators. More RCTs in different parts of world with different forms and doses of Vitamin D are necessary.&lt;br /&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span class="fontstyle2"&gt;&lt;strong&gt;Keywords&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle3"&gt;Nonalcoholic fatty liver disease, systematic review, Vitamin D&lt;/span&gt;&lt;/p&gt;</abstract><web_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/view/2001</web_url><pdf_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/download/2001/717717821</pdf_url></Article><Article><Journal><PublisherName></PublisherName><JournalTitle>International Journal of Preventive Medicine (Int J Prev Med)</JournalTitle><Issn>2008-7802</Issn><Volume>10</Volume><Issue>1</Issue><PubDate PubStatus="epublish"><Year>2019</Year><Month>01</Month><Day>23</Day></PubDate></Journal><title locale="en_US">Appropriate Interventions for Pregnant Women with Indicators of Metabolic Syndrome on Pregnancy Outcomes: A Systematic Review</title><FirstPage>2008</FirstPage><LastPage>7802</LastPage><Language>EN</Language><AuthorList><Author><affiliation locale="en_US">Student Research Committee, School of Nursing and Midwifery, Shahroud University of Medical Sciences, Shahroud</affiliation></Author><Author><affiliation locale="en_US">Faculty Member of Nursing and Midwifery Research Center, Tehran University of Medical Sciences, Tehran</affiliation></Author><Author><affiliation locale="en_US">Department of Midwifery and Reproductive&#13;
Health, School of Nursing and Midwifery, Shahroud University of Medical Sciences, Shahroud</affiliation></Author><Author><affiliation locale="en_US">Reproductive Studies and Women’s Health Research Center, Shahroud University of&#13;
Medical Sciences, Shahroud</affiliation></Author><Author><affiliation locale="en_US">Health Sciences Research Center, Addiction Institute, Mazandaran University of Medical Sciences, Sari</affiliation></Author><Author><affiliation locale="en_US">Shahroud University of MedicalSciences, Shahroud</affiliation></Author></AuthorList><History><PubDate PubStatus="received"><Year>2019</Year><Month>01</Month><Day>23</Day></PubDate></History><abstract locale="en_US">&lt;p&gt;&lt;span class="fontstyle0"&gt;Metabolic syndrome (MetS), a series of symptoms, including abdominal obesity, impaired glucose tolerance and insulin metabolism, hypertension, and dyslipidemia, is considered as the risk of developing cardiovascular disease and diabetes that can predispose a pregnant women to serious&lt;br /&gt;health problem, women in the developed as well as the developing countries. This study was aimed to investigate the effects of appropriate interventions on pregnant women with indicators of MetS to further improve the outcome of pregnancy. This systematic review was performed to extract articles of randomized controlled trials (RCT) on pregnant women with indicators of ( MetS) and focusing on physical activity, dietary or lifestyle interventions on maternal health or perinatal outcomes, with searching in the Web of Science, PubMed, CDSR, Scopus, and Google Scholar were investigated. Two researchers independently evaluated the quality of the studies, being presented in all the articles and ranked the studies as high/low quality; the level of evidence was based on the number of high‑quality studies and the coordination of the obtained results. Then, 17 articles, which met the inclusion criteria, were selected; among these, 7 articles studied the physical activity, 3 articles reviewed diets, 6 probed&lt;br /&gt;the lifestyle interventions, and 1 article was on counseling. In general, evidence suggested how the physical activity and proper diet impacts on proper weight gain during pregnancy, prevents maternal complications, and improves the outcome of pregnancy. According to the results of this systematic review, proper interventions during pregnancy can have a positive effect on maternal weight gain and the general health condition of pregnant women with indicators of MetS. &lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;&lt;/strong&gt;&lt;span class="fontstyle2"&gt;&lt;strong&gt;Keywords&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle3"&gt;Interventions, metabolic syndrome, pregnancy outcomes, pregnant women&lt;/span&gt;&lt;/p&gt;</abstract><web_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/view/1989</web_url><pdf_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/download/1989/717717822</pdf_url></Article><Article><Journal><PublisherName></PublisherName><JournalTitle>International Journal of Preventive Medicine (Int J Prev Med)</JournalTitle><Issn>2008-7802</Issn><Volume>10</Volume><Issue>1</Issue><PubDate PubStatus="epublish"><Year>2019</Year><Month>01</Month><Day>23</Day></PubDate></Journal><title locale="en_US">Overcoming Challenges of Implementing Chronic Care Model in Diabetes Management: An Action Research Approach</title><FirstPage>2008</FirstPage><LastPage>7802</LastPage><Language>EN</Language><AuthorList><Author><affiliation locale="en_US">Nursing and Midwifery Care Research Center, Faculty of Nursing and Midwifery, Isfahan&#13;
University of Medical Sciences, Isfahan</affiliation></Author><Author><affiliation locale="en_US">Nursing and Midwifery Care Research Center, Faculty of Nursing and Midwifery, Isfahan&#13;
University of Medical Sciences, Isfahan</affiliation></Author><Author><affiliation locale="en_US">Nursing and Midwifery Care Research Center, Faculty of Nursing and Midwifery, Isfahan&#13;
University of Medical Sciences, Isfahan</affiliation></Author><Author><affiliation locale="en_US">Endocrinologist, Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan</affiliation></Author><Author><affiliation locale="en_US">Isfahan Social Welfare Organization, Isfahan Shariati Hospital, Heart Section</affiliation></Author><Author><affiliation locale="en_US">Shahid Malakooti Polyclinic of Social Welfare Organization of Isfahan, Diabetes Clinic</affiliation></Author><Author><affiliation locale="en_US">Nurse of Shahid Malakooti Polyclinic of Social Welfare Organization of Isfahan, Diabetes Clinic</affiliation></Author><Author><affiliation locale="en_US">Diabetologist of Diabetes Unit, Shahid Malakooti&#13;
Polyclinic of Social Welfare Organization of Isfahan, Diabetes Clinic</affiliation></Author></AuthorList><History><PubDate PubStatus="received"><Year>2019</Year><Month>01</Month><Day>23</Day></PubDate></History><abstract locale="en_US">&lt;p&gt;&lt;span class="fontstyle0"&gt;&lt;strong&gt;Background&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle2"&gt;Reforming the health care system to improve suitable health care model for diabetic patients is essential. This study aimed to implement, identify, and overcome the challenges of implementing the Chronic Care Model in diabetes management in a clinic.&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;&lt;/strong&gt;&lt;span class="fontstyle0"&gt;&lt;strong&gt;Methods&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle2"&gt;This study is a qualitative technical action research with the Kemmis and McTaggart model including planning, action, reﬂection, observation, and revision plan which was conducted in the specialized polyclinic from 2015 to 2017 in Isfahan city – Iran. Data were gathered through qualitative and quantitative methods. Diabetes team and 17 patients with type 2 diabetes participated in semi-structured&lt;br /&gt;interviews that were purposively chosen. Qualitative data were analyzed using content analysis and then quantitative data collected. &lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;&lt;/strong&gt;&lt;span class="fontstyle0"&gt;&lt;strong&gt;Results&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle2"&gt;The qualitative fndings of this research are in fve main categories: System design upgrade, self-management upgrade, decision support, health care organization, and clinical information system upgrade. Results of quantitative data showed that most metabolic indicators like HbA1c have statistical meaningful changes (&lt;/span&gt;&lt;span class="fontstyle3"&gt;P &lt;/span&gt;&lt;span class="fontstyle2"&gt;value &amp;lt; 0.05).&lt;br /&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span class="fontstyle0"&gt;&lt;strong&gt;Conclusions&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle2"&gt;Implementing the Chronic Care Model became feasible despite serious challenges and two groups of ready and active team and active patients were developed. The study showed that one important lost link of diabetes management is underestimating the nurses’ capabilities in the management of this disease. Inevitably, serious investment on maximum use of nurses’ knowledge and skills in improving diabetes management will help diabetes care upgrade signifcantly.&lt;br /&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span class="fontstyle0" style="color: #00652e;"&gt;Keywords: &lt;/span&gt;&lt;span class="fontstyle3"&gt;Action research, diabetes mellitus type II, disease management, patient‑centered care&lt;/span&gt;&lt;/p&gt;</abstract><web_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/view/2000</web_url><pdf_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/download/2000/717717820</pdf_url></Article><Article><Journal><PublisherName></PublisherName><JournalTitle>International Journal of Preventive Medicine (Int J Prev Med)</JournalTitle><Issn>2008-7802</Issn><Volume>10</Volume><Issue>1</Issue><PubDate PubStatus="epublish"><Year>2019</Year><Month>01</Month><Day>23</Day></PubDate></Journal><title locale="en_US">Clinical Trial of the Effects of Coenzyme Q10 Supplementation on Biomarkers of Inﬂammation and Oxidative Stress in Diabetic Hemodialysis Patients</title><FirstPage>2008</FirstPage><LastPage>7802</LastPage><Language>EN</Language><AuthorList><Author><affiliation locale="en_US">Department of Community Nutrition, School of Nutrition and Food Science, Food Security Research Center, Isfahan University of Medical&#13;
Sciences, Isfahan</affiliation></Author><Author><affiliation locale="en_US">Department of Community Nutrition, School of Nutrition and Food Science, Food Security Research Center, Isfahan University of Medical&#13;
Sciences, Isfahan</affiliation></Author><Author><affiliation locale="en_US">Department of Internal Medicine, Kashan University of Medical Sciences, Kashan</affiliation></Author><Author><affiliation locale="en_US">Isfahan Endocrine and Metabolism Research Center &amp; Department of Biostatistics and Epidemiology, School of Public Health, Isfahan&#13;
University of Medical Sciences, Isfahan</affiliation></Author><Author><affiliation locale="en_US">Research Center for Biochemistry and Nutrition&#13;
in Metabolic Diseases, Kashan University of Medical Sciences, Kashan</affiliation></Author></AuthorList><History><PubDate PubStatus="received"><Year>2019</Year><Month>01</Month><Day>23</Day></PubDate></History><abstract locale="en_US">&lt;p&gt;&lt;span class="fontstyle0"&gt;&lt;strong&gt;Background&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle2"&gt;The aim of the study was to determine the effects of coenzyme Q10 (CoQ10) supplementation on biomarkers of inﬂammation and oxidative stress among diabetic hemodialysis (HD) patients. &lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span class="fontstyle0"&gt;&lt;strong&gt;Methods&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle2"&gt;Sixty diabetic HD patients participated in the randomized, double blind, placebo-controlled clinical trial. They were randomly assigned into two groups to intake either 60 mg CoQ10 supplements (&lt;/span&gt;&lt;span class="fontstyle3"&gt;n &lt;/span&gt;&lt;span class="fontstyle2"&gt;= 30) or placebo (&lt;/span&gt;&lt;span class="fontstyle3"&gt;n &lt;/span&gt;&lt;span class="fontstyle2"&gt;= 30) twice a day for 12 weeks.&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;&lt;/strong&gt;&lt;span class="fontstyle0"&gt;&lt;strong&gt;Results&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle2"&gt;After 12 weeks of intervention, CoQ10 supplementation signifcantly increased total antioxidant (TAC) (54.921 ± 26.437 vs. -126.781 ± 26.437, &lt;/span&gt;&lt;span class="fontstyle3"&gt;P &lt;/span&gt;&lt;span class="fontstyle2"&gt;&amp;lt; 0.001) and nitric oxide (NO) levels (4.121 ± 1.314 vs. -1.427 ± 1.314, &lt;/span&gt;&lt;span class="fontstyle3"&gt;P &lt;/span&gt;&lt;span class="fontstyle2"&gt;= 0.006) and decreased C-reactive protein (CRP) (-1.302 ± 0.583 vs. 0.345 ± 0.583, 0.042) levels compared with the placebo. We did not observe any signifcant effect of CoQ10 supplementation on malondialdehyde (MDA) and glutathione (GSH) levels compared with the placebo. &lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span class="fontstyle0"&gt;&lt;strong&gt;Conclusions&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle2"&gt;Overall, our study showed that CoQ10 supplementation to diabetic HD patients for 12 weeks was associated with increased levels of TAC and NO levels and decreased level of high-sensitivity CRP (hs-CRP) levels, but did not have&lt;br /&gt;any benefcial effects on MDA and GSH.&lt;br /&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span class="fontstyle0" style="color: #00652e;"&gt;&lt;strong&gt;Keywords&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle3"&gt;Coenzyme Q10 supplementation, hemodialysis, inﬂammatory markers, oxidative stress&lt;/span&gt;&lt;/p&gt;</abstract><web_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/view/1999</web_url><pdf_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/download/1999/717717819</pdf_url></Article><Article><Journal><PublisherName></PublisherName><JournalTitle>International Journal of Preventive Medicine (Int J Prev Med)</JournalTitle><Issn>2008-7802</Issn><Volume>10</Volume><Issue>1</Issue><PubDate PubStatus="epublish"><Year>2019</Year><Month>01</Month><Day>23</Day></PubDate></Journal><title locale="en_US">The Variations of Some Salivary Parameters as Probable Indices of the Hereditary Diabetes</title><FirstPage>2008</FirstPage><LastPage>7802</LastPage><Language>EN</Language><AuthorList><Author><affiliation locale="en_US">Department Federico II ENT, Menicagli Roberto Roma Biomed Research Lab, Marotta Ortensio University, Naples</affiliation></Author><Author><affiliation locale="en_US">Department Federico II ENT, Menicagli Roberto Roma Biomed Research Lab, Marotta Ortensio University, Naples</affiliation></Author></AuthorList><History><PubDate PubStatus="received"><Year>2019</Year><Month>01</Month><Day>23</Day></PubDate></History><abstract locale="en_US">&lt;p&gt;&lt;span class="fontstyle0"&gt;&lt;strong&gt;Background&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle2"&gt;Diabetes has a genetic predisposition and is generally not diagnosed for many years because hyperglycemia develops gradually, without presenting the classic symptoms of diabetes. The aim of this study is to verify whether, in a potentially genetically predisposed population,&lt;br /&gt;men and women under the age of 50 years, at the time of the study, not suffering from diabetes can be detected using parameters derived from initial metabolic alteration indices of the possible evolution of pathology. &lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span class="fontstyle0"&gt;&lt;strong&gt;Methods&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle2"&gt;In the hereditary and healthy group, salivary concentration of&lt;br /&gt;malondialdehyde, total mucins, and pH were determined. All participants in the two groups had fasting glucose level below 110 mg/dL. The results were statistically analyzed using Pearson correlation test, Mann–Whitney test, and –Student’s &lt;/span&gt;&lt;span class="fontstyle3"&gt;t&lt;/span&gt;&lt;span class="fontstyle2"&gt;‑test. &lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;&lt;/strong&gt;&lt;span class="fontstyle0"&gt;&lt;strong&gt;Results&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle2"&gt;Salivary concentration of malondialdehyde statistically increased in the hereditary group vs the healthy group (&lt;/span&gt;&lt;span class="fontstyle3"&gt;P &lt;/span&gt;&lt;span class="fontstyle2"&gt;= 0.0368) as the mucins (&lt;/span&gt;&lt;span class="fontstyle3"&gt;P &lt;/span&gt;&lt;span class="fontstyle2"&gt;≤ 0.005). The salivary pH decreased but, the values were not statistically signifcant (&lt;/span&gt;&lt;span class="fontstyle3"&gt;P &lt;/span&gt;&lt;span class="fontstyle2"&gt;= 0.085). Some alteration processes occur without increase in glucose levels, produced by changes in metabolic redox processes along with an increase in the salivary malondialdehyde index of oxidative stress in the body. The modifcation of the salivary buffer system lowers the pH, whereas increase in salivary mucins alters the value of spinnbarkeit, which measures the capacity of the mucous layer to adhere to the epithelium, causing alterations of the oral mucosa.&lt;br /&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span class="fontstyle0"&gt;&lt;strong&gt;Conclusions&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle2"&gt;This study shows that it is possible to predict in hereditary predisposition conditions the development of diabetes, and the related dangerous consequences by monitoring two salivary&lt;br /&gt;parameters – mucins and malondialdehyde.&lt;br /&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span class="fontstyle0" style="color: #00652e;"&gt;&lt;strong&gt;Keywords&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle3"&gt;Diabetes, genetic predisposition, mucins free radicals&lt;/span&gt;&lt;/p&gt;</abstract><web_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/view/1998</web_url><pdf_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/download/1998/717717818</pdf_url></Article><Article><Journal><PublisherName></PublisherName><JournalTitle>International Journal of Preventive Medicine (Int J Prev Med)</JournalTitle><Issn>2008-7802</Issn><Volume>10</Volume><Issue>1</Issue><PubDate PubStatus="epublish"><Year>2019</Year><Month>01</Month><Day>23</Day></PubDate></Journal><title locale="en_US">Effect of Irritable Bowel Syndrome on Sleep Quality and Quality of Life of Inﬂammatory Bowel Disease in Clinical Remission</title><FirstPage>2008</FirstPage><LastPage>7802</LastPage><Language>EN</Language><AuthorList><Author><affiliation locale="en_US">Department of Internal Medicine, Velayat Hospital, Qazvin University of Medical Sciences, Qazvin</affiliation></Author><Author><affiliation locale="en_US">Velayat Clinical Research Development&#13;
Unit, Velayat Hospital, Qazvin University of Medical Sciences, Qazvin</affiliation></Author><Author><affiliation locale="en_US">Velayat Clinical Research Development&#13;
Unit, Velayat Hospital, Qazvin University of Medical Sciences, Qazvin</affiliation></Author><Author><affiliation locale="en_US">Department of Internal Medicine, Metabolic&#13;
Diseases Research Center, Qazvin University of Medical Sciences, Qazvin</affiliation></Author></AuthorList><History><PubDate PubStatus="received"><Year>2019</Year><Month>01</Month><Day>23</Day></PubDate></History><abstract locale="en_US">&lt;p&gt;&lt;span class="fontstyle0"&gt;&lt;strong&gt;Background&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle2"&gt;Inﬂammatory bowel disease (IBD) as a chronic and debilitating disease is affected by sleep disturbance which increases the risk of malignancy. Sleep disturbance is more common in irritable bowel syndrome (IBS) and few reported studies have assessed its role in IBD. We evaluated the effect of IBS on sleep quality and quality of life (QOL) of IBD patients in clinical remission.&lt;br /&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span class="fontstyle0"&gt;&lt;strong&gt;Methods&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle2"&gt;In a cross‑sectional study, 115 IBD patients in clinical remission aged from 14 to 70 years referred to gastroenterology outpatient departments and private gastroenterology offces from 2007 to 2016. Patients considered in four groups (with/without IBS). The Revised “Rome III criteria” used for diagnosing IBS. Pittsburgh Sleep Quality Index questionnaire and the health‑related QOL questionnaire used for evaluating sleep quality and QOL. &lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span class="fontstyle0"&gt;&lt;strong&gt;Results&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle2"&gt;About 85 (73.9%) cases had ulcerative colitis (UC) and 30 (26.1%) cases had Crohn’s disease (CD). Forty (34.8%) cases had IBD + IBS. Poor sleep quality in UC + IBS (OR: 0.018, &lt;/span&gt;&lt;span class="fontstyle3"&gt;P &lt;/span&gt;&lt;span class="fontstyle2"&gt;= 0.003) and UC (OR: 0.016, &lt;/span&gt;&lt;span class="fontstyle3"&gt;P &lt;/span&gt;&lt;span class="fontstyle2"&gt;= 0.002) was less than CD. Diseases extent in left side colitis (OR: 0.064, &lt;/span&gt;&lt;span class="fontstyle3"&gt;P &lt;/span&gt;&lt;span class="fontstyle2"&gt;= 0.016) were less than with pancolitis. Sleep quality affected by quality of life (IBDQ) (&lt;/span&gt;&lt;span class="fontstyle3"&gt;P &lt;/span&gt;&lt;span class="fontstyle2"&gt;= 0.048). Mean quality of life (IBDQ) in patients who had poor sleep was 11% less than those with good sleep. &lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span class="fontstyle0"&gt;&lt;strong&gt;Conclusions&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle2"&gt;The syndrome of IBS affects the sleep quality of IBD in clinical remission, especially in CD. Its additive effect with IBD may worsen symptoms that correlated with sleep disturbance, such as pain, psychological and physical condition, and QOL.&lt;br /&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span class="fontstyle0" style="color: #00652e;"&gt;&lt;strong&gt;Keywords&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle3"&gt;Inﬂammatory bowel diseases, irritable bowel syndrome, quality of life, sleep&lt;/span&gt;&lt;/p&gt;</abstract><web_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/view/1997</web_url><pdf_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/download/1997/717717817</pdf_url></Article><Article><Journal><PublisherName></PublisherName><JournalTitle>International Journal of Preventive Medicine (Int J Prev Med)</JournalTitle><Issn>2008-7802</Issn><Volume>10</Volume><Issue>1</Issue><PubDate PubStatus="epublish"><Year>2019</Year><Month>01</Month><Day>23</Day></PubDate></Journal><title locale="en_US">Ethical Considerations from the Viewpoint of Headquarters Experts on HIV/AIDS Prevention and Control Strategic Program</title><FirstPage>2008</FirstPage><LastPage>7802</LastPage><Language>EN</Language><AuthorList><Author><affiliation locale="en_US">Medical Ethics and Law Research Center, Shahid&#13;
Beheshti University of Medical Sciences, Tehran</affiliation></Author><Author><affiliation locale="en_US">Medical Ethics and Law Research Center, Shahid&#13;
Beheshti University of Medical Sciences, Tehran</affiliation></Author></AuthorList><History><PubDate PubStatus="received"><Year>2019</Year><Month>01</Month><Day>23</Day></PubDate></History><abstract locale="en_US">&lt;p&gt;&lt;span class="fontstyle0"&gt;&lt;strong&gt;Background&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle2"&gt;The HIV control and prevention program is one of the Public Health programs that confronts with many ethical challenges. This study aimed to explore ethical considerations from the viewpoint of headquarters experts on HIV and AIDS prevention and control strategic plan.&lt;br /&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span class="fontstyle0"&gt;&lt;strong&gt;Methods&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle2"&gt;In this qualitative study with content analysis design, focus group discussion method was utilized. After purposeful introduction of the experts and previous coordination about subject and time, two discussion sessions were held with the participation of six ministry and university headquarters&lt;br /&gt;experts of HIV control program. After frequent reviews of the data and using deductive content analysis, main themes and subthemes were categorized. In order to transformability of the fndings to similar situations, the data were checked by three external reviewers. &lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;&lt;/strong&gt;&lt;span class="fontstyle0"&gt;&lt;strong&gt;Results&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle2"&gt;The participants agreed that HIV/AIDS control requires focusing on prevention, treatment, and support services, and considering the general population and all vulnerable groups. In this study, fve main themes were emerged: informing and empowering to make autonomous decisions, observing confdentiality, prohibiting stigma and discrimination, and being accountable. &lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span class="fontstyle0"&gt;&lt;strong&gt;Conclusions&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle2"&gt;The viewpoint of participants indicates on the more need to pay attention the mentioned ethical considerations&lt;br /&gt;when compiling and fnalizing the program. Moreover, in addition to instructing moral norms in PH programs with a special look to HIV/AIDS and how to apply them in the formulation and implementation of program, systematic evaluation of the program by an ethical framework is&lt;br /&gt;recommended to ensure the achievement to the goals of program.&lt;br /&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span class="fontstyle0" style="color: #00652e;"&gt;&lt;strong&gt;Keywords&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle3"&gt;AIDS, HIV, morals/ethics, qualitative research, strategic planning&lt;/span&gt;&lt;/p&gt;</abstract><web_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/view/1995</web_url><pdf_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/download/1995/717717815</pdf_url></Article><Article><Journal><PublisherName></PublisherName><JournalTitle>International Journal of Preventive Medicine (Int J Prev Med)</JournalTitle><Issn>2008-7802</Issn><Volume>10</Volume><Issue>1</Issue><PubDate PubStatus="epublish"><Year>2019</Year><Month>01</Month><Day>23</Day></PubDate></Journal><title locale="en_US">Effects of Intermittent Fasting during Ramadan on Insulin‑like Growth Factor‑1, Interleukin 2, and Lipid Profle in Healthy Muslims</title><FirstPage>2008</FirstPage><LastPage>7802</LastPage><Language>EN</Language><AuthorList><Author><affiliation locale="en_US">Department of Nutrition, Persian Gulf Tropical Medicine Research Center, Bushehr University of Medical Sciences, Bushehr</affiliation></Author><Author><affiliation locale="en_US">Department of Laboratory Technology, Paramedical Faculty, Bushehr University of Medical Sciences, Bushehr</affiliation></Author><Author><affiliation locale="en_US">Department of Nutrition,Student Research&#13;
Committee, Bushehr University of Medical Sciences, Bushehr</affiliation></Author><Author><affiliation locale="en_US">Department of Nutrition,Student Research&#13;
Committee, Bushehr University of Medical Sciences, Bushehr</affiliation></Author><Author><affiliation locale="en_US">Department of Nutrition,Student Research&#13;
Committee, Bushehr University of Medical Sciences, Bushehr</affiliation></Author><Author><affiliation locale="en_US">Department of Nutrition,Student Research&#13;
Committee, Bushehr University of Medical Sciences, Bushehr</affiliation></Author></AuthorList><History><PubDate PubStatus="received"><Year>2019</Year><Month>01</Month><Day>23</Day></PubDate></History><abstract locale="en_US">&lt;p&gt;&lt;span class="fontstyle0"&gt;&lt;strong&gt;Background&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle2"&gt;Insulin‑like growth factor‑1 (IGF‑1) and interleukin‑2 (IL‑2) play an essential role in pathophysiology of several chronic diseases. As a stressor, fasting in Ramadan may increase inﬂammatory markers such as IGF‑1 and IL‑2 in Muslims. The aim of this before–after study was to&lt;br /&gt;investigate the effects of fasting in Ramadan on IGF‑1 and IL‑2 levels in individuals. &lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span class="fontstyle0"&gt;&lt;strong&gt;Methods&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle2"&gt;In all, 34 men age 16–64 years were selected out of the overall number of individuals who were ready for fasting entirely throughout Ramadan. A sample of blood was drawn from the contributors before&lt;br /&gt;and after Ramadan, and plasma IGF‑1, IL‑2, total cholesterol (TC), triglyceride (TG), high‑density lipoprotein cholesterol (HDL‑C), and low‑density lipoprotein cholesterol (LDL‑C) were determined. To identify differences between the initial and fnal values of test results of the study for plasma IGF‑1, IL‑2, and lipid parameters, we used paired sample &lt;/span&gt;&lt;span class="fontstyle3"&gt;T&lt;/span&gt;&lt;span class="fontstyle2"&gt;‑test. &lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span class="fontstyle0"&gt;&lt;strong&gt;Results&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle2"&gt;Paired sample &lt;/span&gt;&lt;span class="fontstyle3"&gt;T&lt;/span&gt;&lt;span class="fontstyle2"&gt;‑test illustrated a signifcant decrease in IGF‑1 and IL‑2 levels after Ramadan fasting compared to before Ramadan. The concentration of TG, cholesterol, and LDL‑C levels underwent signifcant&lt;br /&gt;decreases over the period of the study. HDL‑C levels did not change signifcantly during the study. A signifcant decrease in weight, waist circumferences, calorie, carbohydrate, and fat intake were&lt;br /&gt;observed in participants during Ramadan fasting. &lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span class="fontstyle0"&gt;&lt;strong&gt;Conclusions&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle2"&gt;It is concluded that fasting in Ramadan independent of anthropometric measures attenuates inﬂammation and is benefciary to&lt;br /&gt;health.&lt;br /&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span class="fontstyle0" style="color: #00652e;"&gt;&lt;strong&gt;Keywords&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle3"&gt;Fasting, insulin‑like growth factor‑1, lipids&lt;/span&gt;&lt;/p&gt;</abstract><web_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/view/1994</web_url><pdf_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/download/1994/717717814</pdf_url></Article><Article><Journal><PublisherName></PublisherName><JournalTitle>International Journal of Preventive Medicine (Int J Prev Med)</JournalTitle><Issn>2008-7802</Issn><Volume>10</Volume><Issue>1</Issue><PubDate PubStatus="epublish"><Year>2019</Year><Month>01</Month><Day>23</Day></PubDate></Journal><title locale="en_US">First Report of a Disease by Rhazes 10 Centuries Ago</title><FirstPage>2008</FirstPage><LastPage>7802</LastPage><Language>EN</Language><AuthorList><Author><affiliation locale="en_US">Emergency Medicine Research Team, Tabriz University of Medical Science, Tabriz</affiliation></Author><Author><affiliation locale="en_US">Aging Research Institute, Tabriz University of&#13;
Medical Science, Tabriz</affiliation></Author><Author><affiliation locale="en_US">Aging Research Institute, Tabriz University of&#13;
Medical Science, Tabriz</affiliation></Author><Author><affiliation locale="en_US">Department of Infectious Diseases, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz</affiliation></Author><Author><affiliation locale="en_US">Emergency Medicine Research Team, Tabriz University of Medical Science, Tabriz</affiliation></Author><Author><affiliation locale="en_US">Department of Pediatrics E, Copenhagen Diabetes Research Center (CPH‑DIRECT), Herlev&#13;
University Hospital, Herlev</affiliation></Author><Author><affiliation locale="en_US">Department of Anesthesiology and Intensive Care Medicine, Tabriz University of Medical&#13;
Sciences, Tabriz</affiliation></Author></AuthorList><History><PubDate PubStatus="received"><Year>2019</Year><Month>01</Month><Day>23</Day></PubDate></History><abstract locale="en_US">&lt;p&gt;&lt;span class="fontstyle0"&gt;&lt;strong&gt;Introduction&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle2"&gt;Abu Bakr Mohammad Ibn Zakariya Al‑Razi (865–925 CE), who was known as “Rhazes” in the west, was a famous scientist of medieval ages. He has more than 200 books and treatises. His masterpiece on medicine “&lt;/span&gt;&lt;span class="fontstyle3"&gt;Kitab Al‑Hawi Fi Al‑Tibb&lt;/span&gt;&lt;span class="fontstyle2"&gt;” contains around 900 case reports. Some of the diseases which seem to be recently reported have been stated previously, but not well described. Considering symptoms of the patient described at that time, differential diagnosis will&lt;br /&gt;be discussed. &lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span class="fontstyle0"&gt;&lt;strong&gt;Case presentation&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle2"&gt;Rhazes described a patient with bilious fever. He had developed bloody urine and stool on the fourth day and fatigue. Subsequently, the patient’s urine and stool color turned into dark and black, respectively, and died the following day. According to Rhazes attitude, it was malignant measles. Meyerhof in his book has referred to post‑measles acute glomerulonephritis, but more appropriate differential diagnoses are compatible with this patient. &lt;/span&gt;&lt;span class="fontstyle0"&gt;Discussion: &lt;/span&gt;&lt;span class="fontstyle2"&gt;One of the&lt;br /&gt;best diagnoses for this case can be Weil’s syndrome. Presence of fever, icterus, hemorrhage and renal injury, all suggest Weil’s syndrome without pulmonary involvement. The other probable diagnosis is thrombotic thrombocytopenic purpura (TTP). Meningococcal sepsis is the other possible diagnosis.&lt;br /&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span class="fontstyle0"&gt;&lt;strong&gt;Conclusion&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle2"&gt;To sum up, as three compatible diseases with the case; have been described more than a thousand years after Rhazes (Weil’s syndrome 1886, TTP 1925 and meningococcemia 1805); if the case is either Weil’s or TTP or meningococcal sepsis, it is the frst report of the disease in the world by Rhazes.&lt;br /&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span class="fontstyle0" style="color: #00652e;"&gt;&lt;strong&gt;Keywords&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle3"&gt;Malignant measles, meningococcemia, post‑measles acute glomerulonephritis, Rhazes, thrombotic thrombocytopenic purpura, Weil’s disease&lt;/span&gt;&lt;/p&gt;</abstract><web_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/view/1993</web_url><pdf_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/download/1993/717717813</pdf_url></Article><Article><Journal><PublisherName></PublisherName><JournalTitle>International Journal of Preventive Medicine (Int J Prev Med)</JournalTitle><Issn>2008-7802</Issn><Volume>10</Volume><Issue>1</Issue><PubDate PubStatus="epublish"><Year>2019</Year><Month>01</Month><Day>23</Day></PubDate></Journal><title locale="en_US">Cerium Oxide Nanoparticles Protect Cyclophosphamide‑induced Testicular Toxicity in Mice</title><FirstPage>2008</FirstPage><LastPage>7802</LastPage><Language>EN</Language><AuthorList><Author><affiliation locale="en_US">Department of Anatomy, Faculty of Medicine,&#13;
Molecular and Cell Biology Research Center &amp; Department of Anatomy, Faculty of Medicine,&#13;
Student Research Committee, Mazandaran University of Medical Sciences, Sari</affiliation></Author><Author><affiliation locale="en_US">Department of Radiopharmacy, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari</affiliation></Author><Author><affiliation locale="en_US">Department of Anatomy, Faculty of Medicine,&#13;
Molecular and Cell Biology Research Center, Mazandaran University of Medical Sciences,&#13;
Sari</affiliation></Author><Author><affiliation locale="en_US">Department of Toxicology and Pharmacology, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari</affiliation></Author><Author><affiliation locale="en_US">Department of Anatomy, Faculty of Medicine,&#13;
Molecular and Cell Biology Research Center, Mazandaran University of Medical Sciences,&#13;
Sari</affiliation></Author><Author><affiliation locale="en_US">Department of Anatomy, Faculty of Medicine,&#13;
Molecular and Cell Biology Research Center, Mazandaran University of Medical Sciences,&#13;
Sari</affiliation></Author></AuthorList><History><PubDate PubStatus="received"><Year>2019</Year><Month>01</Month><Day>23</Day></PubDate></History><abstract locale="en_US">&lt;p&gt;&lt;span class="fontstyle0"&gt;&lt;strong&gt;Background&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle2"&gt;Cyclophosphamide (CP), as a chemotherapy drug, causes severe damage in testicular tissue through producing free radicals. Cerium oxide nanoparticles (NC) exhibit antioxidant and anti‑inﬂammatory properties. The purpose of this study was to investigate the protective effect of NC on CP‑induced testicular damage in mice. &lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span class="fontstyle0"&gt;&lt;strong&gt;Methods&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle2"&gt;In this experimental study, thirty‑two male mice were divided into four groups (eight mice in each group). The control group was received intraperitoneally (IP) normal saline, NC group was received NC for three consecutive days (100 &lt;/span&gt;&lt;span class="fontstyle3"&gt;µ&lt;/span&gt;&lt;span class="fontstyle2"&gt;g/kg, IP), CP group was received CP (200 mg/kg, IP), and the CP + NC group received NC, three consecutive days before receiving CP. After 2 days, testicles were assessed for biochemical, histomorphometrical, histopathological, and immunohistochemical analyses. &lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;&lt;/strong&gt;&lt;span class="fontstyle0"&gt;&lt;strong&gt;Results&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle2"&gt;CP administration caused statistically signifcant increases in sperm abnormality, malondialdehyde, protein carbonyl levels, reactive oxygen species, level and apoptosis, and decreases in sperm count, sperm viability, testosterone, glutathione activity, the mean thickness of&lt;br /&gt;the germinal epithelium, diameter of seminiferous tubules in mice. Degeneration, necrosis, arrest of spermatogenesis, congestion, and atrophy in testicular tissue confrmed the low Johnsen’s Testicular&lt;br /&gt;score in CP group. Administration of NC signifcantly ameliorated the CP‑induced adverse effects on testis compared with the CP group. In addition, pretreatment mice with NC signifcantly reduced&lt;br /&gt;caspase‑3 immunoreactivity induced by CP in testis. &lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;&lt;/strong&gt;&lt;span class="fontstyle0"&gt;&lt;strong&gt;Conclusions&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle2"&gt;This study showed that NC with scavenging free radicals and antiapoptotic properties enable to reduce the side effects of CP in the&lt;br /&gt;testicular tissue.&lt;br /&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span class="fontstyle0" style="color: #00652e;"&gt;&lt;strong&gt;Keywords&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle4"&gt;Caspase‑3, cerium oxide, cyclophosphamide, oxidative stress, testis, toxicity&lt;/span&gt;&lt;/p&gt;</abstract><web_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/view/1992</web_url><pdf_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/download/1992/717717812</pdf_url></Article><Article><Journal><PublisherName></PublisherName><JournalTitle>International Journal of Preventive Medicine (Int J Prev Med)</JournalTitle><Issn>2008-7802</Issn><Volume>10</Volume><Issue>1</Issue><PubDate PubStatus="epublish"><Year>2019</Year><Month>01</Month><Day>23</Day></PubDate></Journal><title locale="en_US">Effects of Folate Supplementation on Carotid Intima‑Media Thickness, Biomarkers of Inﬂammation, and Oxidative Stress in Carbamazepine‑Treated Epileptic Children</title><FirstPage>2008</FirstPage><LastPage>7802</LastPage><Language>EN</Language><AuthorList><Author><affiliation locale="en_US">Department of Radiology, Kashan University of Medical Sciences, Kashan</affiliation></Author><Author><affiliation locale="en_US">Department of Radiology, Kashan University of Medical Sciences, Kashan</affiliation></Author><Author><affiliation locale="en_US">Department of Pediatrics, School of Medicine, Kashan University of Medical Sciences, Kashan</affiliation></Author><Author><affiliation locale="en_US">Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical&#13;
Sciences, Kashan</affiliation></Author><Author><affiliation locale="en_US">Department of Radiology, Kashan University of Medical Sciences, Kashan</affiliation></Author><Author><affiliation locale="en_US">Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical&#13;
Sciences, Kashan</affiliation></Author></AuthorList><History><PubDate PubStatus="received"><Year>2019</Year><Month>01</Month><Day>23</Day></PubDate></History><abstract locale="en_US">&lt;p&gt;&lt;span class="fontstyle0"&gt;&lt;strong&gt;Background&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle2"&gt;This study was conducted to assess the effects of folate supplementation on carotid intima‑media thickness (CIMT), biomarkers of inﬂammation, and oxidative stress in carbamazepine‑treated epileptic children. &lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;&lt;/strong&gt;&lt;span class="fontstyle0"&gt;&lt;strong&gt;Methods&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle2"&gt;This randomized, double‑blind, placebo‑controlled&lt;br /&gt;trial was carried out in 54 epileptic children aged 2–12 years old receiving carbamazepine monotherapy. Participants were randomly allocated into two groups to receive either 5 mg folate supplements or placebo (&lt;/span&gt;&lt;span class="fontstyle3"&gt;n &lt;/span&gt;&lt;span class="fontstyle2"&gt;= 27 in each group) for 12 weeks. &lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span class="fontstyle0"&gt;&lt;strong&gt;Results&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle2"&gt;After the 12‑week intervention, compared with the placebo, folate supplementation resulted in a signifcant reduction in plasma homocysteine (Hcy) (changes from baseline - 2.1 ± 2.5 vs. +0.1 ± 0.4 &lt;/span&gt;&lt;span class="fontstyle4"&gt;µ&lt;/span&gt;&lt;span class="fontstyle2"&gt;mol/L, &lt;/span&gt;&lt;span class="fontstyle3"&gt;P &lt;/span&gt;&lt;span class="fontstyle2"&gt;&amp;lt; 0.001), serum high‑sensitivity C‑reactive protein (hs‑CRP) (changes from baseline - 1.5 ± 3.5 vs. +0.4 ± 1.4 mg/L, &lt;/span&gt;&lt;span class="fontstyle3"&gt;P &lt;/span&gt;&lt;span class="fontstyle2"&gt;= 0.01), a signifcant increase in plasma nitric oxide (NO) (changes from baseline + 1.9 ± 5.8 vs.&lt;br /&gt;-2.0 ± 6.4 &lt;/span&gt;&lt;span class="fontstyle4"&gt;µ&lt;/span&gt;&lt;span class="fontstyle2"&gt;mol/L, &lt;/span&gt;&lt;span class="fontstyle3"&gt;P &lt;/span&gt;&lt;span class="fontstyle2"&gt;= 0.02), and total antioxidant capacity (TAC) concentrations (changes from baseline + 88.6 ± 116.0 vs. +1.8 ± 77.4 mmol/L, &lt;/span&gt;&lt;span class="fontstyle3"&gt;P &lt;/span&gt;&lt;span class="fontstyle2"&gt;= 0.002). We did not observe any signifcant effects in mean levels of left and right CIMT, maximum levels of left and right CIMT, and total glutathione (GSH) and malondialdehyde (MDA) levels following the supplementation of folate compared with the placebo.&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;&lt;/strong&gt;&lt;span class="fontstyle0"&gt;&lt;strong&gt;Conclusions&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle2"&gt;Overall, folate supplementation at a dosage of 5 mg/day for&lt;br /&gt;12 weeks among epileptic children receiving carbamazepine had benefcial effects on Hcy, hs‑CRP, NO, and TAC levels, but did not affect CIMT, and GSH and MDA levels.&lt;br /&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span class="fontstyle0" style="color: #00652e;"&gt;&lt;strong&gt;Keywords&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle3"&gt;Carotid intima‑media thickness, epilepsy, folate, inﬂammation, oxidative stress&lt;/span&gt;&lt;/p&gt;</abstract><web_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/view/1991</web_url><pdf_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/download/1991/717717811</pdf_url></Article><Article><Journal><PublisherName></PublisherName><JournalTitle>International Journal of Preventive Medicine (Int J Prev Med)</JournalTitle><Issn>2008-7802</Issn><Volume>10</Volume><Issue>1</Issue><PubDate PubStatus="epublish"><Year>2019</Year><Month>01</Month><Day>23</Day></PubDate></Journal><title locale="en_US">Effect of Natural Honey on Glycemic Control and Anthropometric Measures of Patients with Type 2 Diabetes: A Randomized Controlled Crossover Trial</title><FirstPage>2008</FirstPage><LastPage>7802</LastPage><Language>EN</Language><AuthorList><Author><affiliation locale="en_US">Nutrition Research Center, School of Nutrition and Food Sciences, Shiraz University of Medical Sciences, Shiraz</affiliation></Author><Author><affiliation locale="en_US">Nutrition Research Center, School of Nutrition and Food Sciences, Shiraz University of Medical Sciences, Shiraz</affiliation></Author><Author><affiliation locale="en_US">Nutrition Research Center, School of Nutrition and Food Sciences, Shiraz University of Medical Sciences, Shiraz</affiliation></Author><Author><affiliation locale="en_US">Nutrition Research Center, School of Nutrition and Food Sciences, Shiraz University of Medical Sciences, Shiraz</affiliation></Author></AuthorList><History><PubDate PubStatus="received"><Year>2019</Year><Month>01</Month><Day>23</Day></PubDate></History><abstract locale="en_US">&lt;p dir="LTR"&gt;&lt;strong&gt;Background&lt;/strong&gt;: Due to high content of fructose, honey has been introduced as a suitable natural sweetener for patients with type 2 diabetes. We investigated the effect of honey consumption on glycemic control and anthropometric measures of patients with type 2 diabetes.&lt;/p&gt;&lt;p dir="LTR"&gt;&lt;strong&gt;Methods&lt;/strong&gt;: This randomized controlled crossover clinical trial was conducted on 53 patients with type 2 diabetes. The participants were randomly divided into groups of control (weight maintenance diet) or treatment (weight maintenance diet +50 g/day honey) for 8 weeks. After a 4‑week washout, the second phase began, in which the role of the groups was interchanged. Blood glycated hemoglobin (HbA1c), glucose, insulin, and anthropometric characteristics were measured. Statistical analysis was performed with SPSS. Repeated measures of ANOVA were used to test differences within‑ and between the two conditions. &lt;strong&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p dir="LTR"&gt;&lt;strong&gt;Results&lt;/strong&gt;: Forty‑two patients completed the study. HbA1c signifcantly decreased in control (-0.22%, P = 0.03) and nonsignifcantly increased in honey condition (+0.17%, P = 0.22). There was a signifcant difference between the two conditions (P = 0.02). Fasting glucose did not&lt;br /&gt; signifcantly change in either honey or control condition but insulin concentrations (-0.85 ìU/ml, P = 0.01) and insulin secretion (-10.7%, P = 0.01) decreased signifcantly in the control condition. There was no signifcant difference in any of these parameters between the two conditions. Waist circumference decreased by honey treatment with a signifcant difference between the two conditions (P = 0.02). &lt;strong&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p dir="LTR"&gt;&lt;strong&gt;Conclusions&lt;/strong&gt;: Eight weeks consumption of 50 g/day honey increased HbA1c&lt;br /&gt; and decreased waist circumference of patients with type 2 diabetes.&lt;br /&gt; &lt;strong&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p dir="LTR"&gt;&lt;strong&gt;Keywords&lt;/strong&gt;: Diabetes mellitus, honey, insulin resistance, type 2, waist circumference&lt;/p&gt;</abstract><web_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/view/1990</web_url><pdf_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/download/1990/717717810</pdf_url></Article><Article><Journal><PublisherName></PublisherName><JournalTitle>International Journal of Preventive Medicine (Int J Prev Med)</JournalTitle><Issn>2008-7802</Issn><Volume>10</Volume><Issue>1</Issue><PubDate PubStatus="epublish"><Year>2019</Year><Month>01</Month><Day>23</Day></PubDate></Journal><title locale="en_US">Reading the Nutritional Information on Food Labels Among Teachers with and without Hypertension in Brazil</title><FirstPage>2008</FirstPage><LastPage>7802</LastPage><Language>EN</Language><AuthorList><Author><affiliation locale="en_US">Program of Medical Residency in Clinical Medicine, University Hospital of Londrina, State University of Londrina, State of Paraná</affiliation></Author><Author><affiliation locale="en_US">Department of Pharmacy, University of&#13;
North Paraná, State of Paraná, Londrina</affiliation></Author><Author><affiliation locale="en_US">Department of Public Health, State&#13;
University of Londrina, Paraná State</affiliation></Author><Author><affiliation locale="en_US">Department of Public Health, State&#13;
University of Londrina, Paraná State</affiliation></Author><Author><affiliation locale="en_US">Department of Public Health, State&#13;
University of Londrina, Paraná State</affiliation></Author></AuthorList><History><PubDate PubStatus="received"><Year>2019</Year><Month>01</Month><Day>21</Day></PubDate></History><abstract locale="en_US">&lt;p&gt;&lt;span class="fontstyle0"&gt;&lt;strong&gt;Background&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle2"&gt;To examine the associations among nutritional label use, medically diagnosed hypertension, and sociodemographic factors among teachers. &lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span class="fontstyle0"&gt;&lt;strong&gt;Methods&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle2"&gt;A cross‑sectional study of elementary and secondary school teachers in Londrina, Paraná, Brazil, was conducted. Data regarding&lt;br /&gt;sociodemographic variables, hypertension diagnosis, and the reading of nutritional information on food/beverage labels were collected in 2012–2013. Associations were analyzed using Chi‑square test&lt;br /&gt;or Fisher’s exact test, and multivariate binary logistic regression models were used to adjust for possible confounders; odds ratios (ORs), 95% confdence intervals (CIs), and adjusted &lt;/span&gt;&lt;span class="fontstyle3"&gt;P &lt;/span&gt;&lt;span class="fontstyle2"&gt;values were&lt;br /&gt;calculated. &lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span class="fontstyle0"&gt;&lt;strong&gt;Results&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle2"&gt;Of the 978 teachers interviewed, 15% were diagnosed with hypertension, and 62.5% read nutritional information in the 12 months prior to the survey (41% frequently or always). No differences were found between teachers with and without hypertension with regard to&lt;br /&gt;frequent reading (frequently/always) of nutritional labels. The frequent use of nutritional labels was signifcantly associated with female sex (OR = 1.39; 95% CI = 1.04–1.85) and the highest monthly family income level (OR = 1.82; 95% CI = 1.07–3.11). Teachers with hypertension reported&lt;br /&gt;checking for sodium more frequently than those without (adjusted &lt;/span&gt;&lt;span class="fontstyle3"&gt;P &lt;/span&gt;&lt;span class="fontstyle2"&gt;value = 0.040). Medical advice (adjusted &lt;/span&gt;&lt;span class="fontstyle3"&gt;P &lt;/span&gt;&lt;span class="fontstyle2"&gt;value &amp;lt;0.001) and choosing healthier foods (adjusted &lt;/span&gt;&lt;span class="fontstyle3"&gt;P &lt;/span&gt;&lt;span class="fontstyle2"&gt;value = 0.002) were the major reasons for reading labels provided by teachers with and without hypertension, respectively.&lt;br /&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span class="fontstyle0"&gt;&lt;strong&gt;Conclusions&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle2"&gt;Checking for sodium values on nutritional labels was signifcantly higher among teachers with hypertension, which most likely results from medical advice, and was the major reported reason for reading these labels.&lt;br /&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span class="fontstyle0" style="color: #00652e;"&gt;Keywords: &lt;/span&gt;&lt;span class="fontstyle3"&gt;Food labels, hypertension, nutritional information&lt;/span&gt;&lt;/p&gt;</abstract><web_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/view/1988</web_url><pdf_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/download/1988/717717808</pdf_url></Article><Article><Journal><PublisherName></PublisherName><JournalTitle>International Journal of Preventive Medicine (Int J Prev Med)</JournalTitle><Issn>2008-7802</Issn><Volume>10</Volume><Issue>1</Issue><PubDate PubStatus="epublish"><Year>2019</Year><Month>01</Month><Day>23</Day></PubDate></Journal><title locale="en_US">Look‑Alike Drugs: Avoiding Potential Medical Errors</title><FirstPage>2008</FirstPage><LastPage>7802</LastPage><Language>EN</Language><AuthorList><Author><affiliation locale="en_US">Department of Anaesthesiology, Seth G.S. Medical College and K.E.M. Hospital, Mumbai, Maharashtra</affiliation></Author><Author><affiliation locale="en_US">Department of Anaesthesiology, Seth G.S. Medical College and K.E.M. Hospital, Mumbai, Maharashtra</affiliation></Author><Author><affiliation locale="en_US">Department of Anaesthesiology, Seth G.S. Medical College and K.E.M. Hospital, Mumbai, Maharashtra</affiliation></Author><Author><affiliation locale="en_US">Department of Anaesthesiology, Seth G.S. Medical College and K.E.M. Hospital, Mumbai, Maharashtra</affiliation></Author></AuthorList><History><PubDate PubStatus="received"><Year>2019</Year><Month>01</Month><Day>23</Day></PubDate></History><abstract locale="en_US">--</abstract><web_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/view/1996</web_url><pdf_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/download/1996/717717816</pdf_url></Article></Articles>
